A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SRI SEC filings page.
Stoneridge, Inc (SRI) reported $842.4M in revenue over the twelve months to Sep 30, 2026, up 27.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 shows a shrinking operation where overhead weakened profitability, while working-capital release kept cash flow positive despite a large reported loss.
The key earnings-quality split is that FY2025 produced a net loss of$102.8M but operating cash flow of$34.0M , so accounting losses overstated the cash cost of the year. Inventory and receivables both contracted sharply, a working-capital release that helped free cash flow remain positive after capital spending.
Revenue fell
The financing structure changed materially: long-term debt reached
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Stoneridge, Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Stoneridge, Inc scores 21/100 on it among other operating companies.
Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Stoneridge, Inc scores 14/100 on it among other operating companies.
Stoneridge, Inc carried $1.01 of long-term debt for every $1 of shareholders' equity at the end of fiscal year 2025, a debt-to-equity ratio of 1.01. With no positive EBITDA in fiscal year 2025, Stoneridge, Inc is ranked on that ratio rather than on net debt against EBITDA, a lower ratio being the safer one, and scores 36/100 among other operating companies measured the same way.
Stoneridge, Inc held $2.30 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 2.30. Liquidity ranks operating companies on that ratio, and Stoneridge, Inc scores 66/100 among other operating companies.
Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Stoneridge, Inc scores 29/100 on it among other operating companies.
Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Stoneridge, Inc scores 18/100 on it among other operating companies.
Stoneridge, Inc scores 2.20, placing it in the grey zone between 1.81 and 2.99. The largest contribution to the score comes from revenue of $861.3M against total assets of $551.1M. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Stoneridge, Inc passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 operating efficiency signals passes.
Stoneridge, Inc reported a net loss of $102.8M while generating $34.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Stoneridge, Inc reported an operating loss of $38.6M against $13.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Stoneridge, Inc generated $155.8M in revenue in Q3 2026. This represents an increase of 12.4% from the same quarter a year earlier. Against the prior quarter it is down 14.1%.
Stoneridge, Inc's EBITDA was -$18.3M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 457.9% from the same quarter a year earlier. Against the prior quarter it is down 509.9%.
Stoneridge, Inc reported a net loss of $22.9M in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Stoneridge, Inc earned -$0.81 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
Stoneridge, Inc recorded an outflow of $236K in free cash flow in Q3 2026, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 103.0%.
Stoneridge, Inc held $63.4M in cash against $0 in long-term debt as of Q3 2026, with $364.1M of liabilities due within a year.
Not reported for Q3 2026.
Margins & Returns
Stoneridge, Inc's gross margin was 7.4% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 15.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 12.9 percentage points.
Stoneridge, Inc's operating margin was -15.3% in Q3 2026, reflecting core business profitability. This is down 14.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 14.6 percentage points.
Stoneridge, Inc's net profit margin was -14.7% in Q3 2026, showing the share of revenue converted to profit. This is down 8.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 11.8 percentage points.
Stoneridge, Inc's quarterly ROE was -18.4% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 14.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 14.9 percentage points.
Capital Allocation
Stoneridge, Inc invested $11.4M in research and development in Q3 2026. This represents an increase of 8.5% from the same quarter a year earlier. Against the prior quarter it is down 4.5%.
Stoneridge, Inc invested $4.5M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 29.2% from the same quarter a year earlier. Against the prior quarter it is down 2.4%.
Not reported for Q3 2026.
SRI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $155.8M+12.4% | $181.4M+15.1% | $160.8M+7.9% | $344.4M+57.8% | $138.6M-35.2% | $157.5M-33.5% | $149.1M-37.7% | $218.2M-4.9% |
| Cost of Revenue | $144.3M+35.4% | $144.6M+19.3% | $125.9M+10.6% | $287.6M+63.8% | $106.6M-37.1% | $121.2M-33.9% | $113.8M-40.4% | $175.6M-4.6% |
| Gross Profit | $11.5M-64.1% | $36.8M+1.3% | $35.0M-0.8% | $56.8M+33.1% | $32.1M-27.9% | $36.3M-32.4% | $35.3M-27.1% | $42.7M-6.3% |
| R&D Expenses | $11.4M+8.5% | $12.0M-19.4% | $11.4M-16.7% | $19.5M+5.8% | $10.5M-40.4% | $14.8M-19.6% | $13.7M-22.2% | $18.5M+35.9% |
| SG&A Expenses | $23.9M+3.9% | $26.1M+1.4% | $32.5M+25.8% | $42.4M+48.3% | $23.0M-13.4% | $25.7M-19.4% | $25.9M-15.0% | $28.6M+10.4% |
| Operating Income | -$23.8Mn/m | -$1.2Mn/m | -$9.0Mn/m | -$26.8Mn/m | -$1.4M-555.6% | -$4.2M-223.2% | -$4.3M-1400.9% | -$4.4M-173.6% |
| EBITDA | -$18.3M-457.9% | $4.5M+254.7% | -$3.3M-612.3% | -$14.2M-468.0% | $5.1M-44.2% | $1.3M-89.5% | $640K-92.8% | $3.9M-73.2% |
| Interest Expense | $2.9M-24.6% | $2.4M-25.6% | $3.7M+13.7% | $3.3M-3.1% | $3.8M+5.6% | $3.2M-14.9% | $3.2M-10.8% | $3.4Mn/m |
| Income Tax | -$2.7M-236.5% | $2.6M+65.7% | $1.4M-10.2% | $44.6Mn/m | $2.0M-42.3% | $1.5Mn/m | $1.6M+208.8% | -$60K-128.3% |
| Net Income | -$22.9Mn/m | -$5.3Mn/m | -$27.9Mn/m | -$76.9Mn/m | -$9.4Mn/m | -$9.4M-435.9% | -$7.2Mn/m | -$6.1M-302.2% |
| EPS (Basic) | -$0.81n/m | -$0.19n/m | -$1.00n/m | -$2.77n/m | -$0.34n/m | -$0.34-440.0% | -$0.26n/m | -$0.22-300.0% |
| EPS (Diluted) | -$0.81n/m | -$0.19n/m | -$1.00n/m | -$2.77n/m | -$0.34n/m | -$0.34-440.0% | -$0.26n/m | -$0.22-300.0% |
| Diluted Shares (Avg) | 28M+1.9% | 28M+1.6% | 28M+0.8% | N/A | 28M+0.9% | 28M-0.2% | 28M+0.5% | N/A |
SRI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $510.2M-19.3% | $506.7M-20.8% | $512.0M-22.1% | $551.1M-11.3% | $632.1M-4.6% | $639.4M-4.1% | $657.4M-2.7% | $621.6M-8.6% |
| Current Assets | $350.4M-8.8% | $344.3M-12.5% | $348.0M-16.8% | $361.8M-6.6% | $384.3M-7.3% | $393.4M-6.8% | $418.0M-3.1% | $387.5M-9.8% |
| Cash & Equivalents | $63.4M+17.5% | $71.5M+43.7% | $70.5M-10.8% | $53.1M-26.1% | $54.0M-0.3% | $49.8M+18.2% | $79.1M+63.3% | $71.8M+75.9% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $123.7M-15.0% | $113.0M-21.8% | $111.3M-26.7% | $106.4M-29.7% | $145.4M-17.6% | $144.5M-19.2% | $151.8M-15.6% | $151.3M-19.4% |
| Accounts Receivable | $140.0M-8.5% | $135.7M-16.8% | $140.2M-10.6% | $89.0M-35.4% | $153.1M-3.4% | $163.1M-3.0% | $156.7M-8.0% | $137.8M-17.3% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $36.2M-3.5% | $36.5M-3.1% | $37.0M+6.8% | $37.6M+13.6% | $37.5M+5.4% | $37.7M+10.1% | $34.6M+0.4% | $33.1M-6.3% |
| Total Liabilities | $385.9M+1.3% | $357.6M-5.6% | $355.8M-12.0% | $371.3M-1.3% | $380.9M-2.6% | $378.9M-4.4% | $404.3M+1.5% | $376.3M-4.1% |
| Current Liabilities | $364.1M+102.2% | $182.1M-1.1% | $172.6M-1.5% | $157.5M+5.0% | $180.0M+6.0% | $184.2M-1.1% | $175.2M-2.8% | $150.0M-15.9% |
| Non-Current Liabilities | $21.8M-89.1% | $175.5M-9.9% | $183.2M-20.0% | $213.9M-5.5% | $200.9M-9.2% | $194.7M-7.2% | $229.1M+5.1% | $226.3M+5.8% |
| Long-Term Debt | $0n/m | N/A | N/A | $180.9Mn/m | $0n/m | N/A | N/A | $0n/m |
| Total Equity | $124.3M-50.5% | $149.1M-42.8% | $156.2M-38.3% | $179.8M-26.7% | $251.2M-7.4% | $260.5M-3.7% | $253.1M-8.7% | $245.3M-14.8% |
| Retained Earnings | $21.0M-86.3% | $44.0M-73.1% | $49.2M-71.5% | $77.2M-57.1% | $154.1M-17.2% | $163.4M-15.4% | $172.8M-9.2% | $180.0M-8.4% |
SRI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.2M+3.6% | $12.3M+15.2% | -$11.5M-205.5% | $10.9M-43.1% | $4.1M-62.1% | $10.7M+23.6% | $10.9M+19.6% | $19.2M+81.2% |
| Depreciation & Amortization | $5.5M-15.7% | $5.6M+3.5% | $5.7M+15.2% | $15.6M+87.3% | $6.5M-25.9% | $5.5M-36.2% | $4.9M-42.4% | $8.3M-1.5% |
| Stock-Based Compensation | $706K-35.8% | $1.1M-19.4% | $3.6M+214.3% | N/A | $1.1M+24.2% | $1.4M+27.7% | $1.1M+4.0% | N/A |
| Capital Expenditures | $4.5M-29.2% | $4.6M+39.3% | $836K-86.2% | $6.2M+17.9% | $6.3M+2.8% | $3.3M-53.9% | $6.1M+4.7% | $5.3M-47.0% |
| Free Cash Flow | -$236Kn/m | $7.7M+4.5% | -$12.3M-355.5% | $2.6M-81.2% | -$2.2M-148.0% | $7.4M+384.9% | $4.8M+45.7% | $14.0M+1896.7% |
| Investing Cash Flow | N/A | N/A | N/A | -$6.2Mn/m | -$6.4Mn/m | -$3.2Mn/m | -$6.0Mn/m | -$5.5Mn/m |
| Financing Cash Flow | N/A | N/A | N/A | $9.3M+33.6% | $6.7M+15.7% | -$40.6Mn/m | -$787K-114.6% | $7.0M+258.2% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
SRI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 7.4%-15.8pp | 20.3%-2.8pp | 21.7%-1.9pp | 16.5%-3.1pp | 23.1%+2.3pp | 23.1%+0.4pp | 23.6%+3.4pp | 19.6%-0.3pp |
| Operating Margin | -15.3%-14.2pp | -0.7%+2.0pp | -5.6%-2.7pp | -7.8%-5.8pp | -1.0%-1.2pp | -2.7%-4.1pp | -2.9%-3.0pp | -2.0%-4.7pp |
| Net Margin | -14.7%-8.0pp | -2.9%+3.0pp | -17.4%-12.5pp | -22.3%-19.5pp | -6.8%-3.4pp | -5.9%-7.1pp | -4.8%-2.3pp | -2.8%-4.1pp |
| Return on Equity | -18.4%-14.7pp | -3.5%+0.1pp | -17.9%-15.0pp | -42.8%-40.3pp | -3.7%-1.1pp | -3.6%-4.6pp | -2.8%-0.6pp | -2.5%-3.5pp |
| Return on Assets | -4.5%-3.0pp | -1.0%+0.4pp | -5.5%-4.4pp | -14.0%-13.0pp | -1.5%-0.4pp | -1.5%-1.9pp | -1.1%-0.2pp | -1.0%-1.4pp |
| Current Ratio | 0.96-1.2x | 1.89-0.2x | 2.02-0.4x | 2.30-0.3x | 2.13-0.3x | 2.14-0.1x | 2.390.0x | 2.58+0.2x |
| Debt-to-Equity | 0.000.0x | N/A | N/A | 1.01+1.0x | 0.000.0x | N/A | N/A | 0.000.0x |
| Liabilities-to-Equity | 3.10+1.6x | 2.40+0.9x | 2.28+0.7x | 2.07+0.5x | 1.52+0.1x | 1.450.0x | 1.60+0.2x | 1.53+0.2x |
| Asset Turnover | 0.31+0.1x | 0.36+0.1x | 0.31+0.1x | 0.62+0.3x | 0.22-0.1x | 0.25-0.1x | 0.23-0.1x | 0.350.0x |
| FCF Margin | -0.1%+1.5pp | 4.3%-0.4pp | -7.7%-10.9pp | 0.8%-5.6pp | -1.6%-3.8pp | 4.7%+4.1pp | 3.2%+1.8pp | 6.4%+6.1pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Stoneridge, Inc SRI | FY2025 | $861.3M | -$102.8M | -11.9% | $143.1M | 31/100 |
| Commercial Vehicle Group, Inc. CVGI | FY2025 | $649.0M | -$22.8M | -3.5% | $136.9M | 32/100 |
| Motorcar Parts of America, Inc. MPAA | FY2026 | $789.8M | $12.4M | 1.6% | $140.4M | 54/100 |
| China Automotive Systems, Inc. CAAS | FY2025 | $765.7M | $42.8M | 5.6% | $127.6M | 54/100 |
| Strattec Security Corp STRT | FY2026 | $579.4M | $20.6M | 3.6% | $245.0M | 55/100 |
| SES AI Corporation SES | FY2025 | $21.0M | -$73.0M | N/A | $189.5M | 77/100 |
Where Stoneridge, Inc Ranks
Frequently Asked Questions
Stoneridge, Inc (SRI) reported $861.3M in total revenue for fiscal year 2025. This represents a -5.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Stoneridge, Inc (SRI) revenue declined by 5.2% year-over-year, from $908.3M to $861.3M in fiscal year 2025.
No, Stoneridge, Inc (SRI) reported a net loss of $133.0M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $102.8M, with a net profit margin of -11.9%.
Stoneridge, Inc (SRI) had EBITDA of -$6.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, Stoneridge, Inc (SRI) had $53.1M in cash and equivalents against $180.9M in long-term debt.
Stoneridge, Inc (SRI) had a gross margin of 19.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Stoneridge, Inc (SRI) had an operating margin of -4.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Stoneridge, Inc (SRI) had a net profit margin of -11.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Stoneridge, Inc (SRI) has a return on equity of -57.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Stoneridge, Inc (SRI) generated $12.2M in free cash flow during fiscal year 2025. This represents a -48.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Stoneridge, Inc (SRI) generated $34.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Stoneridge, Inc (SRI) had $551.1M in total assets as of fiscal year 2025, including both current and long-term assets.
Stoneridge, Inc (SRI) invested $21.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Stoneridge, Inc (SRI) invested $62.5M in research and development during fiscal year 2025.
Stoneridge, Inc (SRI) had a current ratio of 2.30 as of fiscal year 2025, which is generally considered healthy.
Stoneridge, Inc (SRI) had a debt-to-equity ratio of 1.01 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Stoneridge, Inc (SRI) had a liabilities-to-equity ratio of 2.07 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Stoneridge, Inc (SRI) had a return on assets of -18.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Stoneridge, Inc (SRI) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $143.1M as of Nov 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Stoneridge, Inc (SRI) trades at 0.2x sales, its market capitalization divided by $842.4M revenue, trailing 12 months to September 30, 2026. The market capitalization is $143.1M as of Nov 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Stoneridge, Inc (SRI) has an Altman Z-Score of 2.20, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Stoneridge, Inc (SRI) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Stoneridge, Inc (SRI) reported a net loss of $102.8M while generating $34.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Stoneridge, Inc (SRI) reported an operating loss of $38.6M against $13.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
Stoneridge, Inc (SRI) scores 31 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.